Research library / Longevity compounds

BB Good human data, but mixed outcomes or surrogate markers. How we grade →Meta-analysis of RCTs · 25 trials, 1,024 people, 0.5 to 6 g a day

Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials

C Tzang, L Chi, L Lin et al. Nutrition & Diabetes. 2024.

Published Sources checked 1 sourceEverstack research teamHow we work

In plain language
Taurine lowered systolic (about 4 mm Hg) and diastolic (about 1.5 mm Hg) blood pressure, fasting glucose (about 5.9 mg/dL) and triglycerides (about 18 mg/dL).
Limits
Lab and blood pressure markers, not disease outcomes; trials short (5 to 365 days); Taiwanese public funding.
Which of our grades it feeds
  • DD Mostly mechanistic or early data. Shown openly. How we grade →Science summary: Taurine and aging
Source
doi.org/10.1038/s41387-024-00289-z · PubMed 38755142 · Free full text

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.